taurocholic acid has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chislov, M; Kumeev, R; Promzeleva, M; Proshin, A; Terekhova, I; Volkova, T | 1 |
| Değim, Z; Eşsiz, D; Mutlu, NB; Nacar, A; Yilmaz, Ş | 1 |
2 other study(ies) available for taurocholic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimer's Disease Prevention.
Topics: Alzheimer Disease; Drug Design; Micelles; Molecular Structure; Sodium Dodecyl Sulfate; Solubility; Taurocholic Acid; Thiadiazoles | 2018 |
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Topics: Alzheimer Disease; Animals; beta-Cyclodextrins; Biological Availability; Brain; Cell Line; Cholinesterase Inhibitors; Dogs; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Neuroprotective Agents; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2011 |